Search Results - "Kawata, Nozomu"

Refine Results
  1. 1

    An ERG Gene Analysis in Two Cases with Metastatic Castration-resistant Prostate Cancer in Which Abiraterone Demonstrated Long-term Efficacy by Yoshizawa, Tsuyoshi, Yamaguchi, Kenya, Kawata, Nozomu, Ryuzaki, Hitomi, Ogawa, Masahiro, Obinata, Daisuke, Mochida, Junichi, Takahashi, Satoru

    Published in Internal Medicine (01-02-2020)
    “…We analyzed the ERG gene status using fluorescence in situ hybridization (FISH) in two chemotherapy-naïve cases with metastatic castration-resistant prostate…”
    Get full text
    Journal Article
  2. 2

    Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma by Sato, Aya, Nagase, Hiroki, Obinata, Daisuke, Fujiwara, Kyoko, Fukuda, Noboru, Soma, Masayoshi, Yamaguchi, Kenya, Kawata, Nozomu, Takahashi, Satoru

    Published in International journal of oncology (01-11-2013)
    “…We investigated the clinical significance of the expression levels of matrix metalloproteinase 9 (MMP-9) in renal cell carcinoma (RCC). In addition, we…”
    Get full text
    Journal Article
  3. 3

    TIMP-1 as well as Microvessel Invasion and High Nuclear Grade Is a Significant Determinant Factor for Extension of Tumor Diameter in Localized RCC by Takahashi, Satoru, Igarashi, Tomohiro, Yamaguchi, Kenya, Kawata, Nozomu

    Published in Journal of Oncology (01-01-2016)
    “…Objectives. To clarify what kind of pathological factor is necessary for the extension of tumor diameter in localized RCC, we studied localized RCC patients…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract by Hirano, Daisaku, Okada, Yasuhiro, Nagane, Yusuke, Satoh, Katsuhiko, Mochida, Junichi, Yamanaka, Yataroh, Hirakata, Hitoshi, Yamaguchi, Kenya, Kawata, Nozomu, Takahashi, Satoru, Henmi, Akihiro

    Published in Urologia internationalis (01-01-2012)
    “…To elucidate clinicopathological risk factors for intravesical recurrence (IVR) in patients undergoing nephroureterectomy for upper urinary tract urothelial…”
    Get more information
    Journal Article
  6. 6

    How do symptoms have an impact on the prognosis of renal cell carcinoma? by Kawata, Nozomu, Nagane, Yusuke, Yamaguchi, Kenya, Ichinose, Taketo, Hirakata, Hitoshi, Takahashi, Satoru

    Published in International journal of urology (01-04-2008)
    “…Aim:  Symptomatic renal cell carcinoma (RCC) is well known to have a characteristic behavior. We therefore evaluated the impact of systemic symptoms on the…”
    Get full text
    Journal Article
  7. 7

    Histopathological analysis of angiogenic factors in renal cell carcinoma by YAGASAKI, HIROKI, KAWATA, NOZOMU, TAKIMOTO, YUKIE, NEMOTO, NORIMICHI

    Published in International journal of urology (01-04-2003)
    “…Aim: The present study was carried out to clarify whether a histopathological analysis of vascular endothelial growth factor (VEGF), transforming growth…”
    Get full text
    Journal Article
  8. 8

    Metastasectomy for renal cell carcinoma as a strategy to obtain complete remission by Yamaguchi, Kenya, Kawata, Nozomu, Nagane, Yusuke, Igarashi, Hiroshi, Sugimoto, Shuji, Hirakata, Hitoshi, Takahashi, Satoru, Higaki, Tokio

    Published in International journal of clinical oncology (01-10-2010)
    “…We report a case of 67-year-old Japanese woman with two types of metastasectomy for metachronous metastases of renal cell carcinoma (RCC). The initial…”
    Get full text
    Journal Article
  9. 9

    Usefulness of contrast-enhanced ultrasound for the diagnosis of recurrent renal cell carcinoma in contralateral kidney by KAWATA, NOZOMU, IGARASHI, TAKUMI, ICHINOSE, TAKETO, HIRAKATA, HITOSHI, HACHIYA, TAKAHIKO, TAKIMOTO, YUKIE, OGAWA, MASAHIRO

    Published in International journal of urology (01-03-2006)
    “…We studied contrast‐enhanced ultrasound (CEU) for recurrence of renal cell carcinoma (RCC) at the contralateral kidney during postoperative follow up of…”
    Get full text
    Journal Article
  10. 10

    Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival by HACHIYA, TAKAHIKO, ICHINOSE, TAKETO, HIRAKATA, HITOSHI, KAWATA, NOZOMU, OKADA, KIYOKI, TAKIMOTO, YUKIE

    Published in International journal of urology (01-04-2006)
    “…Objective:  This study attempts to determine whether prostate‐specific antigen (PSA) failure following radical retropubic prostatectomy (RRP) affects patients’…”
    Get full text
    Journal Article
  11. 11

    Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: A single institutional study by HACHIYA, TAKAHIKO, OKADA, YASUHIRO, KAWATA, NOZOMU, HIRANO, DAISAKU, YOSHIDA, TOSHIO, OKADA, KIYOKI, TAKIMOTO, YUKIE

    Published in International journal of urology (01-10-2004)
    “…Background:  We evaluated the outcome of radical prostatectomy to provide information about long‐term survival following this procedure. Methods:  One hundred…”
    Get full text
    Journal Article
  12. 12

    Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: The influence of neoadjuvant treatment by Kawata, Nozomu, Yagasaki, Hiroki, Yuge, Humikazu, Nakanoya, Yuji, Fujimura, Kei, Sugimoto, Shuji, Hirakata, Hitoshi, Takimoto, Yukie

    Published in International journal of urology (01-06-2001)
    “…Background: This study was conducted in order to clarify whether histopathologic analysis of factor thymidine phosphorylase (TP) and Factor VIII could be a…”
    Get full text
    Journal Article
  13. 13
  14. 14

    An ERG Gene Analysis in Two Cases with Metastatic Castration-resistant Prostate Cancer in which Abiraterone Demonstrated Long-term Efficacy by Yoshizawa, Tsuyoshi, Yamaguchi, Kenya, Kawata, Nozomu, Ryuzaki, Hitomi, Ogawa, Masahiro, Obinata, Daisuke, Mochida, Junichi, Takahashi, Satoru

    Published in Internal Medicine (2020)
    “…We analyzed the ERG gene status using fluorescence in situ hybridization (FISH) in two chemotherapy-naïve cases with metastatic castration-resistant prostate…”
    Get full text
    Journal Article
  15. 15
  16. 16

    OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis) by Yokoyama, Osamu, Honda, Masashi, Yamanishi, Tomonori, Sekiguchi, Yuki, Fujii, Kenji, Nakayama, Takashi, Mogi, Takao, Kitta, Takeya, Ohyama, Chikara, Kambe, Koichi, Tanahashi, Yoshikatsu, Sasagawa, Isoji, Ootani, Mikinobu, Nozawa, Eiyu, Saito, Toshihiko, Manabe, Fumio, Suzuki, Yasutomo, Tomoe, Hikaru, Takahashi, Satoru, Kawata, Nozomu, Matsushima, Hisashi, Kawai, Taketo, Kinjo, Manami, Fukagai, Takashi, Takahashi, Atsuko, Nakajima, Fumio, Sasaki, Haruaki, Okuno, Norihiko, Itoi, Toshiyuki, Ishiura, Yoshiyuki, Mizokami, Atsushi, Matsuta, Yosuke, Sawada, Norifumi, Miwa, Kosei, Otsuka, Atsushi, Funahashi, Yasuhito, Yoshida, Masaki, Tobiume, Motoi, Kawauchi, Akihiro, Okuno, Hiroshi, Nakamura, Terukazu, Ninomiya, Noriko, Matsushita, Chie, Takenaka, Atsushi, Watanabe, Takeshi, Watanabe, Toyohiko, Ishito, Noritaka, Yamamoto, Yasuyo, Ikeda, Hiroshi, Seki, Narihito, Kanegae, Shigehiro, Suyama, Kenichi, Sagiyama, Kazuyuki, Tokuda, Noriaki, Sakai, Hideki, Nishimura, Hiroaki, Kawahara, Motoshi

    Published in International journal of urology (01-03-2020)
    “…Objective To evaluate the efficacy and safety of onabotulinumtoxinA (botulinum toxin type A) 100 U in patients with overactive bladder and urinary…”
    Get full text
    Journal Article
  17. 17

    Cytoreductive surgery with liver‐involved renal cell carcinoma by Kawata, Nozomu, Hirakata, Hitoshi, Yuge, Humikazu, Kodama, Masahito, Sugimoto, Shuji, Yagasaki, Hiroki, Mochida, Junichi, Fujimura, Kei, Takimoto, Yukie

    Published in International journal of urology (01-10-2000)
    “…The purpose of this study was to demonstrate the benefits of cytoreductive surgery for renal cell carcinomas that also involve the liver. Between 1994 and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Significant Relationship of Matrix Metalloproteinase 9 with Nuclear Grade and Prognostic Impact of Tissue Inhibitor of Metalloproteinase 2 for Incidental Clear Cell Renal Cell Carcinoma by Kawata, Nozomu, Nagane, Yusuke, Hirakata, Hitoshi, Ichinose, Taketo, Okada, Yasuhiro, Yamaguchi, Kenya, Takahashi, Satoru

    Published in Urology (Ridgewood, N.J.) (01-06-2007)
    “…Objective To examine the immunoreactivity of tumors for matrix metalloproteinases 2 and 9 (MMP-2, MMP-9), tissue inhibitors of metalloproteinases 1 and 2…”
    Get full text
    Journal Article